Antipsychotic medicines cause obesity and diabetes

In 2008, roughly 14.3 million Americans were taking antipsychotics—typically prescribed for bipolar disorder, schizophrenia, or a number of other behavioral disorders—making them among the most prescribed drugs in the U.S. Almost all of these medications are known to cause the metabolic side effects of obesity and diabetes, leaving patients with a difficult choice between improving their mental health and damaging their physical health.

continue reading

Decaffeinated coffee preserves memory by improving brain energy

Decaffeinated coffee may improve brain energy metabolism associated with type 2 diabetes. This brain dysfunction is a known risk factor for dementia and other neurodegenerative disorders like Alzheimer’s disease.

continue reading

Homoeoapthic medicines are immuno-modulators – a scientific explanation

Homoeopathic Medicine Are Nothing But The Chemical Imaging Of The Drug Substance On The Vehicle ( Milk Sugar, Sugar, Alcohol Or Water) Which Will Be Better Explained By Photochemistry, Which Is Different Of Each Medical Substance In Different Potencies.

Health :: New insight into childhood metabolic disease

Glutaric acidemia type I (GA-I) is an inherited disorder similar to Huntington disease. Individuals with GA-I are unable to breakdown completely the amino acids lysine and tryptophan and the intermediates of lysine and tryptophan breakdown accumulate in the brain. In most, but not all, affected children, a period of normal development is followed by an irreversible brain injury triggered by a nonspecific illness.

Blood Pressure :: Women with high or increasing blood pressure are up to three times more likely to develop diabetes

One of the largest studies to investigate the relationship between blood pressure and type 2 diabetes has found that women who have high blood pressure levels are three times more likely to develop diabetes than women with low blood pressure levels. This effect was independent of body mass index and other conditions that are known to predispose people to cardiovascular disease and diabetes.

Diabetes :: New IDF guidelines raise importance of post-meal glucose control

The International Diabetes Federation (IDF) has published new guidelines on the contribution and impact of post-meal glucose in diabetes disease management at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) on September_19, 2007. The IDF recognises the growing evidence that post-meal glucose is a key contributor to overall glycaemic control – particularly with respect to HbA1C levels, and that reducing post-meal glucose has a significant impact on the risk of developing diabetic complications.

Spirit India